MEGAN STITELY-BRENNEMAN: Open Payments
NPI 1235682600 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,099 in 27 payments from 18 companies in 2025. Trend: 2023 $1,312 · 2024 $1,457 · 2025 $2,099
Food & beverage: $2,099
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $348 |
| Novo Nordisk Inc | 4 | $283 |
| Xeris Pharmaceuticals, Inc. | 3 | $188 |
| Dexcom, Inc. | 1 | $115 |
| GlaxoSmithKline, LLC. | 1 | $114 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Hologic Sales and Service, LLC | 1 | $104 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Amgen Inc. | 1 | $102 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
Products named: Wegovy, BREZTRI, AIRSUPRA, DEXCOM G7 GSS (161), AREXVY, INJECTAFER, APTIMA, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
